Antioxidant protection from HIV-1 gp120-induced neuroglial toxicity

Journal of Neuroinflammation

Volumn 1, Issue , 2004, Pages

  Walsh, Kimberly A ^a   Megyesi, Joseph F ^a   Wilson, John X ^a   Crukley, Jeff ^a   Laubach, Victor E ^b   Hammond, Robert R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID 2 PHOSPHATE; CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN GP 120; INDUCIBLE NITRIC OXIDE SYNTHASE; MICROTUBULE ASSOCIATED PROTEIN 2;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FETUS; GESTATION PERIOD; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MOUSE; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

EID: 4344639844     PISSN: 17422094     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-2094-1-8     Document Type: Article

References (97)

1. Davies J, Everall IP, Weich S, Glass J, Sharer LR, Cho ES, Bell JE, Majteny C, Gray F, Scaravilli F, Lantos PL: HIV-associated brain pathology: a comparative international study. Neuropathol Appl Neurobiol 1998, 24:118-124.
2. Hofman P, Saint-Paul MC, Battaglione V, Michiels JF, Loubiere R: Autopsy findings in the acquired immunodeficiency syndrome (AIDS). A report of 395 cases from the south of France. Pathol Res Pract 1999, 195:209-217.
3. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P: The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988, 239:586-592.
4. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA: Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992, 32:321-329.
5. Wiley CA, Achim C: Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994, 36:673-676.
6. Budka H: Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991, 1:163-175.
7. Kaul M, Garden GA, Lipton SA: Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994.
8. Lipton SA: Neuronal injury associated with HIV-1: approaches to treatment. Annu Rev Pharmacol Toxicol 1998, 38:159-177.
9. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I: Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997, 42:963-972.
10. Everall IP, Luthert PJ, Lantos PL: Neuronal loss in the frontal cortex in HIV infection. Lancet 1999, 337:1119-1121.
11. Scorziello A, Florio T, Bajetto A, Schettini G: Intracellular signalling mediating HIV-1 gp120 neurotoxicity. Cell Signal 1998, 10:75-84.
12. Corasaniti MT, Bagetta G, Rotiroti D, Nistico G: The HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro. Biochem Pharmacol 1998, 56:153-156.
13. Savio T, Levi G: Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res 1993, 34:265-272.
14. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L: Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994, 367:188-193.
15. Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, Gabuzda D: Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 1996, 98:1979-1990.
16. Giulian D, Wendt E, Vaca K, Noonan CA: The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A 1993, 90:2769-2773.
17. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB: Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991, 7:111-118.
18. Torre D, Pugliese A, Speranza F: Role of nitric oxide in HIV-1 infection: friend or foe? Lancet Infect Dis 2002, 2:273-280.
19. Wang Y, Marsden PA: Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 1995, 34:71-90.
20. Espey MG, Miranda KM, Thomas DD, Wink DA: Distinction between nitrosating mechanisms within human cells and aqueous solution. J Biol Chem 2001, 276:30085-30091.
21. Brown GC: Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 2001, 1504:46-57.
22. Moncada S, Erusalimsky JD: Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol 2002, 3:214-220.
23. Radi R, Cassina A, Hodara R: Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002, 383:401-409.
24. Murphy MP: Nitric oxide and cell death. Biochim Biophys Acta 1999, 1411:401-414.
25. Salgo MG, Stone K, Squadrito GL, Battista JR, Pryor WA: Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem Biophys Res Commun 1995, 210:1025-1030.
26. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS: DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991, 254:1001-1003.
27. Zhang J, Dawson VL, Dawson TM, Snyder SH: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994, 263:687-689.
28. Lautier D, Lagueux J, Thibodeau J, Menard L, Poirier GG: Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem 1993, 122:171-193.
29. Scorziello A, Florio T, Bajetto A, Schettini G: Intracellular signalling mediating HIV-1 gp120 neurotoxicity. Cell Signal 1998, 10:75-84.
30. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA: Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992, 32:321-329.
31. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I: Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997, 42:963-972.
32. Rafaeli Y, Levy DN, Weiner DB: The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc Natl Acad Sci U S A 1995, 92:3621-3625.
33. Pozzoli G, Tringali G, Dello RC, Vairano M, Preziosi P, Navarra P: HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase. J Neuroimmunol 2001, 118:268-276.
34. Dugas N, Lacroix C, Kilchherr E, Delfraissy JF, Tardieu M: Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis. 2001, 15:96-107.
35. Dawson VL, Dawson TM, Uhl GR, Snyder SH: Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci U S A 1993, 90:3256-3259.
36. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L: HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002, 8:136-142.
37. Everall IP, Hudson L, Kerwin RW: Decreased absolute levels of ascorbic acid and unaltered vasoactive intestinal polypeptide receptor binding in the frontal cortex in acquired immunodeficiency syndrome. Neurosci Lett 1997, 224:119-122.
38. Korcok J, Wu F, Tyml K, Hammond RR, Wilson JX: Sepsis inhibits reduction of dehydroascorbic acid and accumulation of ascorbate in astroglial cultures: intracellular ascorbate depletion increases nitric oxide synthase induction and glutamate uptake inhibition. J Neurochem 2002, 81:185-193.
39. Pulliam L, Berens ME, Rosenblum ML: A normal human brain cell aggregate model for neurobiological studies. J Neurosci Res 1988, 21:521-530.
40. Hammond RR, Iskander S, Achim CL, Hearn S, Nassif J, Wiley CA: A reliable primary human CNS culture protocol for morphological studies of dendritic and synaptic elements. J Neurosci Methods 2002, 118:189-198.
41. Halliwell B: Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett 2003, 540:3-6.
42. Laubach VE, Shesely EG, Smithies O, Sherman PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide- induced death. Proc Natl Acad Sci U S A 1995, 92:10688-10692.
43. Dixon SJ, Wilson JX: Fluorescence measurement of cytosolic pH in cultured rodent astrocytes. 1995, 27:196-213.
44. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH: Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A 1992, 89:6711-6715.
45. Lyons CR, Orloff GJ, Cunningham JM: Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992, 267:6370-6374.
46. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA: Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992, 32:321-329.
47. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R: Neocortical damage during HIV infection. Ann Neurol 1991, 29:651-657.
48. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE: Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 1995, 182:941-951.
49. Brosnan CF, Lee SC, Liu J: Regulation of inducible nitric oxide synthase expression in human glia: implications for inflammatory central nervous system diseases. Biochem Soc Trans 1997, 25:679-683.
50. Minghetti L, Levi G: Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 1998, 54:99-125.
51. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP: Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 1993, 16:323-328.
52. Zhao ML, Kim MO, Morgello S, Lee SC: Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol 2001, 115:182-191.
53. Hori K, Burd PR, Furuke K, Kutza J, Weih KA, Clouse KA: Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. Blood 1999, 93:1843-1850.
54. Heneka MT, Feinstein DL: Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol 2001, 114:8-18.
55. Minc-Golomb D, Tsarfaty I, Schwartz JP: Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br J Pharmacol 1994, 112:720-722.
56. Sato I, Kim Y, Himi T, Murota S: Induction of calcium-independent nitric oxide synthase activity in cultured cerebellar granule neurons. Neurosci Lett 1995, 184:145-148.
57. Sasaki S, Shibata N, Komori T, Iwata M: iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci Lett 2000, 291:44-48.
58. Vodovotz Y, Lucia MS, Flanders KC, Chesler L, Xie QW, Smith TW, Weidner J, Mumford R, Webber R, Nathan C, Roberts AB, Lippa CF, Sporn MB: Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 1996, 184:1425-1433.
59. Smith MA, Richey HP, Sayre LM, Beckman JS, Perry G: Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997, 17:2653-2657.
60. Vodovotz Y, Lucia MS, Flanders KC, Chesler L, Xie QW, Smith TW, Weidner J, Mumford R, Webber R, Nathan C, Roberts AB, Lippa CF, Sporn MB: Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 1996, 184:1425-1433.
61. Maxwell SR: Prospects for the use of antioxidant therapies. Drugs 1995, 49:345-361.
62. Pratico D, Delanty N: Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med 2000, 109:577-585.
63. Shaw PJ, Ince PG, Falkous G, Mantle D: Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995, 38:691-695.
64. Gilgun-Sherki Y, Melamed E, Offen D: Oxidative stress induced- neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. 2001, 40:959-975.
65. Everall IP, Hudson L, Kerwin RW: Decreased absolute levels of ascorbic acid and unaltered vasoactive intestinal polypeptide receptor binding in the frontal cortex in acquired immunodeficiency syndrome. Neurosci Lett 1997, 224:119-122.
66. Stone JR, Collins T: The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 2002, 9:231-238.
67. Cai H, Li Z, Davis ME, Kanner W, Harrison DG, Dudley SC Jr: Aktdependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol 2003, 63:325-331.
68. Thomas CE, Huber EW, Ohlweiler DF: Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: implications for protection of biological substrates. Free Radic Biol Med 1997, 22:733-737.
69. Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, Cohen RA: Modulation by peroxynitrite of Akt- and AMP-activated kinasedependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem 2002, 277:32552-32557.
70. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL: Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917-1921.
71. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD: Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994, 36:778-786.
72. Haas J, Storch-Hagenlocher B, Biessmann A, Wildemann B: Inducible nitric oxide synthase and argininosuccinate synthetase: coinduction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett 2002, 322:121-125.
73. Iravani MM, Kashefi K, Mander P, Rose S, Jenner P: Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. 2002, 110:49-58.
74. Orihara Y, Ikematsu K, Tsuda R, Nakasono I: Induction of nitric oxide synthase by traumatic brain injury. Forensic Sci Int 2001, 123:142-149.
75. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL: Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917-1921.
76. Klegeris A, Walker DG, McGeer PL: Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by nonsteroidal anti-inflammatory drugs (NSAIDs). 1999, 38:1017-1025.
77. Klegeris A, McGeer PL: Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J Leukoc Biol 2000, 67:127-133.
78. Piani D, Spranger M, Frei K, Schaffner A, Fontana A: Macrophageinduced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 1992, 22:2429-2436.
79. Piani D, Frei K, Pfister HW, Fontana A: Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor. J Neuroimmunol 1993, 48:99-104.
80. Piani D, Fontana A: Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 1994, 152:3578-3585.
81. Barger SW, Basile AS: Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem 2001, 76:846-854.
82. Mizutani A, Maki H, Torii Y, Hitomi K, Tsukagoshi N: Ascorbate- dependent enhancement of nitric oxide formation in activated macrophages. Nitric Oxide 1998, 2:235-241.
83. Wu F, Tyml K, Wilson JX: Ascorbate inhibits iNOS expression in endotoxin- and IFN gamma-stimulated rat skeletal muscle endothelial cells. FEBS Lett 2002, 520:122-126.
84. Martin E, Nathan C, Xie QW: Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994, 180:977-984.
85. Xie QW, Whisnant R, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 1993, 177:1779-1784.
86. Hecker M, Preiss C, Klemm P, Busse R: Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: role of nuclear factor kappa B and interferon regulatory factor 1. Br J Pharmacol 1996, 118:2178-2184.
87. Adams V, Nehrhoff B, Spate U, Linke A, Schulze PC, Baur A, Gielen S, Hambrecht R, Schuler G: Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study. Cardiovasc Res 2002, 54:95-104.
88. Han YJ, Kwon YG, Chung HT, Lee SK, Simmons RL, Billiar TR, Kim YM: Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages. Nitric Oxide 2001, 5:504-513.
89. Kim SH, Johnson VJ, Shin TY, Sharma RP: Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-kappaB signaling pathways. Exp Biol Med (Maywood) 2004, 229:203-213.
90. Liu X, Jana M, Dasgupta S, Koka S, He J, Wood C, Pahan K: Human immunodeficiency virus type-1 (HIV-1) Tat induces nitric oxide synthase in human astroglia. J Biol Chem 2002, 277:39312-39319.
91. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Bosca L, Leza JC: Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem 2001, 76:532-538.
92. Matsumura M, Kakishita H, Suzuki M, Banba N, Hattori Y: Dexamethasone suppresses iNOS gene expression by inhibiting NFkappaB in vascular smooth muscle cells. Life Sci 2001, 69:1067-1077.
93. Nomura Y: NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci 2001, 68:1695-1701.
94. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Neurology 1998, 50:645-651.
95. Carrillo MC, Kitani K, Kanai S, Sato Y, Miyasaka K, Ivy GO: The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats. Biochem Pharmacol 1994, 47:1333-1338.
96. Carrillo MC, Ivy GO, Milgram NW, Head E, Wu P, Kitani K: (-) Deprenyl increases activities of superoxide dismutase (SOD) in striatum of dog brain. Life Sci 1994, 54:1483-1489.
97. Carrillo MC, Kitani K, Kanai S, Sato Y, Miyasaka K, Ivy GO: (-)deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice. Life Sci 1994, 54:975-981.